Lee Shulman, MD
Obstetrics & Gynecology · Chicago, ILNPI 1164447413
Payments from drug & device makers
Across 512 payments — averaging $1126.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$243K
- Astellas Pharma US Inc$67K
- Agile Therapeutics, Inc.$64K
- Daiichi Sankyo Inc.$59K
- Aspira Women's Health Inc$24K
- Merck$18K
- plus $102K from 19 others
What the payments were for
- Consulting fees$72,07413%
- Speaking & faculty fees$417,18775%
- Travel & lodging$51,2369%
- Food & beverage$17,9963%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 173 | $242,983 |
| Astellas Pharma US Inc | 61 | $67,418 |
| Agile Therapeutics, Inc. | 70 | $63,613 |
| Daiichi Sankyo Inc. | 68 | $59,069 |
| Aspira Women's Health Inc | 13 | $23,669 |
| Merck | 3 | $18,300 |
| Shield Therapeutics Inc | 8 | $17,020 |
| BD | 11 | $15,651 |
| Lupin Inc. | 24 | $14,863 |
| Astellas Pharma Global Development | 8 | $11,610 |
| Evofem Biosciences, Inc. | 17 | $10,897 |
| Mckesson Corporation | 1 | $5,215 |
| Scynexis, Inc. | 9 | $5,044 |
| Bayer | 6 | $4,715 |
| Exeltis, USA Inc. | 2 | $4,227 |
| Medicem Inc. | 10 | $4,086 |
| Roche Diagnostics Corporation | 5 | $3,749 |
| Coopersurgical, Inc. | 5 | $2,773 |
| AMAG Pharmaceuticals, Inc. | 4 | $819 |
| AbbVie(2 entities) | 3 | $768 |
| American Regent | 4 | $147 |
| Myovant Sciences Inc. | 3 | $109 |
| Abbott | 2 | $59 |
| Sumitomo Pharma America, Inc. | 1 | $45 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXTSTELLIS$177,523
- ANNOVERA$81,235
- Veozah$77,448
- Twirla$62,563
- INJECTAFER$58,407
- BIJUVA$27,820
- OVA1$23,497
- ACCRUFER$16,898
- SOLOSEC$14,263
- Phexxi$10,679
- Slynd$4,227
- DILAPAN-S$4,075
- TD VENTANA Primary Staining Instruments and Reagents$2,650
- Paragard$2,500
- MAKENA$750
- RS Harmony Test Related Products$654
- LILETTA$650
- MD cobas Instruments and Reagents$445
- PARAGARD T 380A$100
How this compares
$576,861 in reported general payments places this provider in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 74 | $9,209 |
| Estradiol (Once Weekly)Estradiol | 11 | $1,457 |
| ProgesteroneProgesterone, Micronized | 22 | $1,114 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chicago
- Maria TamChicago$378K
- Amy WhitakerChicago$351K
- Gregory UrsinoChicago$242K
- Magdy MiladChicago$211K
- Joseph ThomasChicago$180K
- Ayman Al-HendyChicago$142K
- Nicole TaskerChicago$125K
- Ashlesha PatelChicago$81K
- Teresa HubkaChicago$62K
- Angela ChaudhariChicago$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.